What is driving the rapid growth of fish gelatin?

Fish gelatin satisfies halal requirements, avoids swine-related disease volatility and aligns with regulators’ push for non-mammalian excipients, enabling a 6.56% CAGR through 2030. Read More

How large is the pharmaceutical gelatin market today?

The market is valued at USD 1.35 billion in 2025 and is projected to hit USD 1.75 billion by 2030, growing at a 5.45% CAGR. Read More

Why are soft-gel capsules gaining traction?

Soft-gels improve bioavailability for lipid-soluble drugs and vitamins, and technology advances such as EASYSEAL reduce leakage, supporting a 6.97% CAGR for this format. Read More

What supply-chain risks threaten gelatin availability?

African swine fever periodically disrupts porcine hide supply, causing price spikes and prompting buyers to diversify into fish and bovine sources. Read More

Are plant-based capsules a major competitive threat?

Regulatory sustainability agendas in Europe and North America encourage hydroxypropyl-methylcellulose shells, but gelatin retains technical advantages for soft-gels and biologic stabilizers, limiting near-term displacement. Read More

Pharmaceutical Gelatin Companies

This report lists the top Pharmaceutical Gelatin companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Pharmaceutical Gelatin industry.